These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2514010)

  • 1. The effects of serotonergic and dopaminergic lesions on sodium-sensitive [3H]mazindol binding in rat hypothalamus and corpus striatum.
    Angel I; Janowsky A; Paul SM
    Brain Res; 1989 Dec; 503(2):339-41. PubMed ID: 2514010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transport of [3H]mazindol binding sites in mesostriatal dopamine axons.
    O'Dell SJ; Marshall JF
    Brain Res; 1988 Sep; 460(2):402-6. PubMed ID: 3147121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [3H]mazindol binding associated with neuronal dopamine and norepinephrine uptake sites.
    Javitch JA; Blaustein RO; Snyder SH
    Mol Pharmacol; 1984 Jul; 26(1):35-44. PubMed ID: 6087116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential visualization of dopamine and norepinephrine uptake sites in rat brain using [3H]mazindol autoradiography.
    Javitch JA; Strittmatter SM; Snyder SH
    J Neurosci; 1985 Jun; 5(6):1513-21. PubMed ID: 4009243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential response of striatal dopamine and muscarinic cholinergic receptor subtypes to the loss of dopamine. I. Effects of intranigral or intracerebroventricular 6-hydroxydopamine lesions of the mesostriatal dopamine system.
    Joyce JN
    Exp Neurol; 1991 Sep; 113(3):261-76. PubMed ID: 1833219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of surgical and chemical lesions on striatal [3H]threo-(+/-)-methylphenidate binding: correlation with [3H]dopamine uptake.
    Janowsky A; Schweri MM; Berger P; Long R; Skolnick P; Paul SM
    Eur J Pharmacol; 1985 Jan; 108(2):187-91. PubMed ID: 3920060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of characteristics of dopamine uptake and mazindol binding in mouse striatum.
    Zimányi I; Lajtha A; Reith ME
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Dec; 340(6):626-32. PubMed ID: 2615854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [3H]mazindol binding associated with neuronal dopamine uptake sites in corpus striatum membranes.
    Javitch JA; Blaustein RO; Snyder SH
    Eur J Pharmacol; 1983 Jun; 90(4):461-2. PubMed ID: 6884434
    [No Abstract]   [Full Text] [Related]  

  • 9. [3H]cocaine binding and inhibition of [3H]dopamine uptake is similar in both the rat striatum and nucleus accumbens.
    Boja JW; Kuhar MJ
    Eur J Pharmacol; 1989 Dec; 173(2-3):215-7. PubMed ID: 2625137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thermodynamic analyses of the binding of substrates and uptake inhibitors on the neuronal carrier of dopamine labeled with [3H]GBR 12783 or [3H]mazindol.
    Bonnet JJ; Benmansour S; Costentin J; Parker EM; Cubeddu LX
    J Pharmacol Exp Ther; 1990 Jun; 253(3):1206-14. PubMed ID: 2141637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [3H]GBR-12935 binding to dopamine uptake sites in rat striatum.
    Allard PO; Eriksson K; Ross SB; Marcusson JO
    Neuropsychobiology; 1990-1991; 23(4):177-81. PubMed ID: 2130286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mazindol and amphetamine as inhibitors of the uptake and releasers of 3H-dopamine by rat striatal synaptosomes.
    Carruba MO; Picotti GB; Zambotti F; Mantegazza P
    Naunyn Schmiedebergs Arch Pharmacol; 1977 May; 298(1):1-5. PubMed ID: 882144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of striatal acetylcholine release by serotonin and dopamine after the intracerebral administration of 6-hydroxydopamine to neonatal rats.
    Jackson D; Bruno JP; Stachowiak MK; Zigmond MJ
    Brain Res; 1988 Aug; 457(2):267-73. PubMed ID: 3146404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of [3H]mazindol binding in rat brain: sodium-sensitive binding correlates with the anorectic potencies of phenylethylamines.
    Angel I; Luu MD; Paul SM
    J Neurochem; 1987 Feb; 48(2):491-7. PubMed ID: 3467029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [3H]tyramine binding: a comparison with neuronal [3H]dopamine uptake and [3H]mazindol binding processes.
    Vaccari A; Gessa G
    Neurochem Res; 1989 Oct; 14(10):949-55. PubMed ID: 2532713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoradiographic studies in animal models of hemi-parkinsonism reveal dopamine D2 but not D1 receptor supersensitivity. I. 6-OHDA lesions of ascending mesencephalic dopaminergic pathways in the rat.
    Graham WC; Crossman AR; Woodruff GN
    Brain Res; 1990 Apr; 514(1):93-102. PubMed ID: 2113410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine high-affinity transport site topography in rat brain: major differences between dorsal and ventral striatum.
    Marshall JF; O'Dell SJ; Navarrete R; Rosenstein AJ
    Neuroscience; 1990; 37(1):11-21. PubMed ID: 2243588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions between serotonergic and enkephalinergic neurons in rat striatum and hypothalamus.
    Dellavedova L; Parenti M; Tirone F; Groppetti A
    Eur J Pharmacol; 1982 Nov; 85(1):29-34. PubMed ID: 7151862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Location and effect of obesity on putative anorectic binding sites in the rat brain.
    Dunn-Meynell AA; Levin BE
    Obes Res; 1997 May; 5(3):201-7. PubMed ID: 9192394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between [3H]mazindol binding to dopamine uptake sites and [3H]dopamine uptake in rat striatum during aging.
    Shimizu I; Prasad C
    J Neurochem; 1991 Feb; 56(2):575-9. PubMed ID: 1988557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.